Antiviral properties of two trimeric recombinant gp41 proteins

BACKGROUND: As it is the very first step of the HIV replication cycle, HIV entry represents an attractive target for the development of new antiviral drugs. In this context, fusion inhibitors are the third class of anti-HIV drugs to be used for treatment, in combination with nucleoside analogues and...

Descripción completa

Detalles Bibliográficos
Autores principales: Delcroix-Genête, Delphine, Quan, Phenix-Lan, Roger, Marie-Gaëlle, Hazan, Uriel, Nisole, Sébastien, Rousseau, Cécile
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1435769/
https://www.ncbi.nlm.nih.gov/pubmed/16515685
http://dx.doi.org/10.1186/1742-4690-3-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1435769/
https://www.ncbi.nlm.nih.gov/pubmed/16515685
http://dx.doi.org/10.1186/1742-4690-3-16

Ejemplares similares